The investigators found that OV can favorably alter tumor microenvironment (elevated CD8+ T cells, upregulation of INF-gamma, and increased expression of PD-L1 protein) resulted in improved response to the immune checkpoint inhibitor [28]. The gene discussed is CD8A; the disease is neoplasm.